(2'S,4aR,4bS,6aS,7aS,8aS,8bS,8cR,8dR,9aR)-4a,6a-dimethyl-4,4a,4b,5,6,6a,7a,8,8a,8b,8c,8d,9,9a-tetradecahydro-3'H-spiro[cyclopropa[4,5]cyclopenta[1,2-a]cyclopropa[l]phenanthrene-7,2'-furan]-2,5'(3H,4'H)-dione;6?,7?,15?,16?-Dimethylene-3-oxo-4-androstene-[17(?-1’)-spiro-5’]perhydrofuran-2’-one; 3-Oxo-6?,7?:15?,16?-dimethylene-17?-pregn-4-en-21,17-carbolactone; 1,2-Dihydrospirorenone; Dihydrospirorenone; Drospirenona; YAZ; ZK 30595;Drospirenone; Spiro[17H-dicyclopropa[6,7:15,16]cyclopenta[a]phenanthrene-17 ,2'(5'H)-furan]-3,5'(2H)-dione
Drospirenone is a fully characterized chemical compound used as a reference standard of API Lumacaftor. The standard offered is compliant with regulatory guidelines. Drospirenone is used for analytical method development, method validation (AMV), and Quality Controlled (QC) applications during synthesis and formulation stages of drug development and serves as a reference standard for traceability against pharmacopeial standards (USP or EP). Axios Research products are intended for analytical purposes only and are not for human use. CAS - NA
Related products
Drospirenone
Drospirenone
Drospirenone
Drospirenone
Drospirenone
Drospirenone
Drospirenone
Drospirenone
Drospirenone
Drospirenone
Drospirenone
Drospirenone
Drospirenone
Drospirenone
Drospirenone
Drospirenone
Drospirenone
Drospirenone
Drospirenone
Drospirenone
Drospirenone
Drospirenone
Drospirenone
Drospirenone
Drospirenone
Drospirenone
6ß,7ß,15ß,16ß-Dimethylene-3ß,5ß-dihydroxyandostan-17-one
M.F.
M.W. 330.47
CAT# AR-D02487
CAS# 82543-16-6
Drospirenone
3β,5β-Dihydroxy-15β,16β-methylene-androst-6-en-17-one
M.F.
M.W. 316.44
CAT# AR-D02491
CAS# 82543-15-5
Drospirenone
Drospirenone
Drospirenone
Drospirenone
Drospirenone